Description
DEOBLIGATION OF EXCESS FUNDS FOR FY24 AND FY25 - RADIOACTIVE ISOTOPES XOFIGO
Base award description: RADIOACTIVE ISOTOPES XOFIGO
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-11-30+$386,860= $386,860
- Mod P000012024-08-26+$0= $386,860
- Mod P000022024-10-01+$386,860= $773,720
- Mod P000032026-03-24-$425,478= $348,242
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-11-30 | +$386,860 | $386,860 | RADIOACTIVE ISOTOPES XOFIGO |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-08-26 | +$0 | $386,860 | RADIOACTIVE ISOTOPES XOFIGO |
| Mod P00002· EXERCISE AN OPTION | 2024-10-01 | +$386,860 | $773,720 | RADIOACTIVE ISOTOPES XOFIGO |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-03-24 | −$425,478 | $348,242 | DEOBLIGATION OF EXCESS FUNDS FOR FY24 AND FY25 - RADIOACTIVE ISOTOPES XOFIGO |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI V1EVGCK7XES8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0492 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $386,860 | FY2026 |
| 36C26226F0163 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $181,386 | FY2026 |
| 36C26026F0086 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $80,663 | FY2026 |
| 36C26126N0199 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $101,567 | FY2026 |
| 36C25626N0126 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $214,783 | FY2026 |
| 36E79725A0028 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626N0555 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $654,692 | FY2026 |
| 36C25626P0618 | HANGER PROSTHETICS & ORTHOTICS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $15,119 | FY2026 |
| 36C25626N0469 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $396,000 | FY2026 |
| 36C25626N0461 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $271,226 | FY2026 |
| 36C25626P0466 | ON TARGET LABORATORIES, INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $42,650 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25624N0388_3600_36F79720D0237_3600 · retrieved 2026-09-26.